Market Cap 8.60M
Revenue (ttm) 0.00
Net Income (ttm) -82.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.10
Volume 1,562,500
Avg Vol 4,676,562
Day's Range N/A - N/A
Shares Out 44.95M
Stochastic %K 0%
Beta 0.45
Analysts Strong Buy
Price Target N/A

Company Profile

NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. Its lead products include SNK01, an autologous NK cell therapy candidate treatment for neurodegenerative diseases; and SNK02, an allogeneic NK cell therapy, which is in Phase 1 clinical trials for refractory solid tumors. The company has a license agreement with NKMAX. The company was formerly known as NK...

Industry: Biotechnology
Sector: Healthcare
Phone: 949-396-6830
Address:
3001 Daimler Street, Santa Ana, United States
biotechexplorer
biotechexplorer Jun. 20 at 6:02 PM
$NKGN Now that the NKMax deal is approved, it appears that Mr. Song will be working with Heka Bio to market troculeucel throughout Asia. Heka Bio is a private healthcare company in Japan and recently hired a commercial development manager. NKGen is listed on their partners page. In addition, Alfresa Holdings just made a capital investment in HekaBio this week. Finally, Paul Song was in Japan yesterday visiting Heka Bio, so the cards are lining up nicely.
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 20 at 12:02 PM
$NKGN clears final hurdle for NKMAX acquisition with stakeholder approval - deal set to close by August. While this brings manufacturing capabilities and IP, investors should note: NKGen's $8K cash position and negative equity (-$47M) make this a high-wire act. Acquisition success = existential. https://www.sec.gov/Archives/edgar/data/1845459/000121390025055833/ea0246125-8k_nkgen.htm
1 · Reply
RupertDCat
RupertDCat Jun. 19 at 5:29 PM
$NKGN $NKGN What is the plan for NKMax now that the acquisition is going to happen? Is it primarily for their production capability or something else? Will this allow NKGen to start selling their Alzheimer’s solution in Korea since regulations and approvals are not as strict.
1 · Reply
junglezoo
junglezoo Jun. 19 at 8:13 AM
$NKGN NKMax Successfully Acquired According to the investment banking (IB) industry on the 19th, NKMax has received court approval for its rehabilitation plan, including a confirmed investment agreement with U.S.-based NKGen Biotech. NKGen plans to acquire 46.4 million new shares of NKMax for 23.2 billion KRW (about $17 million USD). Samjong KPMG served as the lead M&A advisor. With this transaction, NKGen Biotech will become NKMax’s largest shareholder, holding 65.01% of the company. Read details via link. https://www.chosun.com/economy/money/2025/06/19/AE7N23RIADKWFWEMNMBHIUOXF4/?outputType=amp
1 · Reply
Picklerinthekitchen
Picklerinthekitchen Jun. 18 at 8:52 PM
$NKGN crappy day on this one again !
0 · Reply
DENNISF1
DENNISF1 Jun. 18 at 8:49 PM
$NKGN THIS IS GONNA SUPRISE!
0 · Reply
DENNISF1
DENNISF1 Jun. 18 at 8:48 PM
$NKGN THIS IS VERY VERY RISKY AND CRAZY SHORTING. BEARS BEWARE! OUTSTANDING SHARES 53, 900,487! POSTING FOR THE #SQUEEZERBULLS. 😉 LET'S GET'M!!!
0 · Reply
DENNISF1
DENNISF1 Jun. 17 at 4:00 AM
$NKGN not leaving the OTC pot of gold. Remember i said it!
0 · Reply
DENNISF1
DENNISF1 Jun. 17 at 3:58 AM
0 · Reply
vu_jade
vu_jade Jun. 16 at 2:59 PM
$NKGN maybe 20C
0 · Reply
Latest News on NKGN
No data available.
biotechexplorer
biotechexplorer Jun. 20 at 6:02 PM
$NKGN Now that the NKMax deal is approved, it appears that Mr. Song will be working with Heka Bio to market troculeucel throughout Asia. Heka Bio is a private healthcare company in Japan and recently hired a commercial development manager. NKGen is listed on their partners page. In addition, Alfresa Holdings just made a capital investment in HekaBio this week. Finally, Paul Song was in Japan yesterday visiting Heka Bio, so the cards are lining up nicely.
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 20 at 12:02 PM
$NKGN clears final hurdle for NKMAX acquisition with stakeholder approval - deal set to close by August. While this brings manufacturing capabilities and IP, investors should note: NKGen's $8K cash position and negative equity (-$47M) make this a high-wire act. Acquisition success = existential. https://www.sec.gov/Archives/edgar/data/1845459/000121390025055833/ea0246125-8k_nkgen.htm
1 · Reply
RupertDCat
RupertDCat Jun. 19 at 5:29 PM
$NKGN $NKGN What is the plan for NKMax now that the acquisition is going to happen? Is it primarily for their production capability or something else? Will this allow NKGen to start selling their Alzheimer’s solution in Korea since regulations and approvals are not as strict.
1 · Reply
junglezoo
junglezoo Jun. 19 at 8:13 AM
$NKGN NKMax Successfully Acquired According to the investment banking (IB) industry on the 19th, NKMax has received court approval for its rehabilitation plan, including a confirmed investment agreement with U.S.-based NKGen Biotech. NKGen plans to acquire 46.4 million new shares of NKMax for 23.2 billion KRW (about $17 million USD). Samjong KPMG served as the lead M&A advisor. With this transaction, NKGen Biotech will become NKMax’s largest shareholder, holding 65.01% of the company. Read details via link. https://www.chosun.com/economy/money/2025/06/19/AE7N23RIADKWFWEMNMBHIUOXF4/?outputType=amp
1 · Reply
Picklerinthekitchen
Picklerinthekitchen Jun. 18 at 8:52 PM
$NKGN crappy day on this one again !
0 · Reply
DENNISF1
DENNISF1 Jun. 18 at 8:49 PM
$NKGN THIS IS GONNA SUPRISE!
0 · Reply
DENNISF1
DENNISF1 Jun. 18 at 8:48 PM
$NKGN THIS IS VERY VERY RISKY AND CRAZY SHORTING. BEARS BEWARE! OUTSTANDING SHARES 53, 900,487! POSTING FOR THE #SQUEEZERBULLS. 😉 LET'S GET'M!!!
0 · Reply
DENNISF1
DENNISF1 Jun. 17 at 4:00 AM
$NKGN not leaving the OTC pot of gold. Remember i said it!
0 · Reply
DENNISF1
DENNISF1 Jun. 17 at 3:58 AM
0 · Reply
vu_jade
vu_jade Jun. 16 at 2:59 PM
$NKGN maybe 20C
0 · Reply
BCINU
BCINU Jun. 11 at 4:22 PM
$NKGN going to $1 + and maybe buyout the $5 + in the next year
1 · Reply
vu_jade
vu_jade Jun. 6 at 2:58 PM
$NKGN I’ll add around 13c
1 · Reply
Picklerinthekitchen
Picklerinthekitchen Jun. 6 at 4:42 AM
0 · Reply
vu_jade
vu_jade Jun. 4 at 3:44 AM
$NKGN insider buying 13c?
1 · Reply
BCINU
BCINU Jun. 3 at 5:02 PM
$NKGN this company has a future and reward to hold will pay off big time
0 · Reply
BloodMeridian1
BloodMeridian1 Jun. 3 at 1:51 PM
$NKGN Andrew and Peggy Cherng, founders of Panda Express, have made significant investments through their family office, the Cherng Family Trust. This trust manages their wealth, including investments in real estate and various industries. In 2015, they purchased a $15.2 million beachfront mansion in Honolulu through their investment company, CFIC-2014 NV Family Investments LLC, which is managed by Cherng Family Investments LLC.
1 · Reply
PenkeTrading
PenkeTrading Jun. 3 at 4:29 AM
I found you a MACD Bearish Reversal Divergence on the daily chart of NKGen Biotech, Inc. Common Stock. $NKGN #NKGen #BearishReversalDivergence #PINK
0 · Reply
MoneyMediary
MoneyMediary Jun. 3 at 2:05 AM
$NKGN Nkgen Biotech NKGN just saw a 944% increase in insider ownership. CFIC-2015 NV Family Investments dumped $2.5M into the stock at $0.13. That’s not a trim, that’s a moonshot bet from someone who knows what’s coming. https://moneymediary.com/p/biotech-insider-goes-all-in-on-2-5m-bet
2 · Reply
RupertDCat
RupertDCat Jun. 2 at 8:26 PM
$NKGN https://www.investing.com/news/insider-trading-news/nkgen-biotech-sees-25-million-stock-purchase-by-major-shareholder-93CH-4076379
0 · Reply
Abdullah5566
Abdullah5566 Jun. 2 at 7:06 PM
$NKGN any news !!!? we have been waiting long time
1 · Reply
BCINU
BCINU Jun. 2 at 6:38 PM
$NKGN hoping this take offs or buyout
0 · Reply
jParkz
jParkz Jun. 2 at 6:30 PM
News Article Expected US Company Earnings on Monday, June 2nd, 2025 https://marketwirenews.com/news-releases/expected-us-company-earnings-on-monday-june-2nd-2025-8005213852453608.html $NKGN
0 · Reply